Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance : vimarsana.com

/PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons...

Related Keywords

United States , American , Renee Kelley , Facebook Invitae , Kevin Hughes , Ed Esplin , Instagram , American Society Of Breast Surgeons Annual Meeting , University Of South Carolina Department Surgery , Invitae Corporation , Exchange Commission , Breast Surgeons Annual Meeting , Clinical Geneticist , World Breast Surgery Utilization , Breast Cancer Patients , Germline Variants , Uncertain Significance , Cancer Genetics , Medical University , South Carolina Department , Private Securities Litigation Reform Act , Quarterly Report , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Otc , Mallcap , Clinical Trials Amp Medical Discoveries , Trade Show News ,